Management of mTOR inhibitors oral mucositis: current state of knowledge
Introduction: Mucositis is a well-known side effect of classic anticancer treatments (chemotherapy and radiotherapy). Thanks to the major developments in personalizing treatments through the development of targeted treatment, various specific intraoral lesions have been described. Purpose: mTOR inhi...
Saved in:
Main Authors: | Calvo Anne Sophie (Author), Rochefort Juliette (Author), Javelot Marie José (Author), Descroix Vianney (Author), Lescaille Géraldine (Author) |
---|---|
Format: | Book |
Published: |
EDP Sciences,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Knowledge and practices of dentists in France regarding oral mucosal diseases: a national survey
by: Roume Maud, et al.
Published: (2019) -
Pharmacological mTOR inhibitors in ameliorating Alzheimer's disease: current review and perspectives
by: Pei-Lun Xie, et al.
Published: (2024) -
Clinical photography: attitudes of practitioners specialized in oral mucosal diseases
by: Olugbeje Helen, et al.
Published: (2021) -
mTOR in Human Diseases
by: Dormond, Olivier
Published: (2019) -
Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients
by: Mathis Wehming, et al.
Published: (2023)